<DOC>
	<DOCNO>NCT02095548</DOCNO>
	<brief_summary>The purpose study find optimal dose SM04690 safely give intra-articular injection target knee joint subject moderate severe osteoarthritis .</brief_summary>
	<brief_title>Phase 1 , Dose Escalation Study Evaluating Safety , Tolerability , Pharmacokinetics Pharmacodynamics SM04690 Moderate Severe Knee Osteoarthritis ( OA )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Diagnosed primary OA target knee American College Rheumatology ( ACR ) criteria Screening pain criterion sufficient assess WOMAC VAS score Ability read understand inform consent Women pregnant lactate child bear potential , men must use barrier method contraception Any condition , include laboratory finding , opinion investigator constitute risk contraindication participation study could interfere study objective , conduct evaluation Body mass index &gt; 40 Major knee surgery target knee within 12 month prior study plan surgery study period History malignancy within last 5 year Participation clinical research trial within 12 week prior Treatment target knee intraarticular steroid within 2 month hyaluronic acid derivative within 6 month Effusion target knee require aspiration within 3 month Use electrotherapy acupuncture OA within 4 week Significant clinically evident misalignment target knee Any known active infection Any chronic condition well control minimum 3 month</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>